Compounded tirzepatide
Embody vs GobyMeds
Quick answer
Embody costs $129 a real month and GobyMeds costs $145 — a difference of $16 a month, or $187 a year. Both figures are computed from what each seller actually charges and how often, not from the price on its landing page.
What each one bills
| Embody | GobyMeds | |
|---|---|---|
| True monthly cost | $129 | $145 |
| Advertised as | $129 | $133 |
| Charged | every calendar month | every 12 weeks |
| Each charge | $129 | $399 |
| Price basis | the same at every dose | a starting-dose price that climbs |
| Mandatory recurring fee | none found | none found |
| States it names | 50 states | not published |
| FDA warning letter | none on record | none on record |
We earn a commission if you start care through one of the links above, at no extra cost to you. Which of these two is cheaper is computed from what each one bills and nothing else.
Where they actually differ
- They bill on different clocks. Embody charges every calendar month and GobyMeds charges every 12 weeks. That alone changes what a “month” costs, which is the whole reason this index recomputes every price.
- One price holds and the other climbs. Embody’s price is the same at every dose; GobyMeds’s is a starting-dose price that climbs. See what titration does to an advertised figure.
- What they advertise is not what they bill. GobyMeds advertises $133 and bills $145.
How we know
Both figures were read on the seller’s own site and recomputed over a 30.4375-day calendar month from the charge and the billing period it covers. Neither is a seller’s own “/mo”. The full working for each — the charge, the period, the arithmetic and the date it was read — is on its own page: Embody and GobyMeds. The method is set out in how we verify.
To compare any two sellers in the index rather than these two, use the comparison tool.